Ildong Pharmaceutical Reports Operating Loss of 1.3 Billion KRW in Q1... Returns to Deficit
[Asia Economy Reporter Park Jihwan] Ildong Pharmaceutical announced on the 7th that its operating loss for the first quarter of this year turned to a deficit of 1.3 billion KRW.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
During the same period, sales increased by 7.3% to 138.5 billion KRW. Net loss for the period was 1.1 billion KRW, turning to a deficit from a net profit of 6 billion KRW the previous year.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
